Once , few years ago someone asked Dr NP during CC
Post# of 148181
He nicely answered that in biotech one don't answer about it this way , because price is not only what they pay today for drug , but all the expenses , including research and studies for so many years before the drug is developed , than approved , and when patent expire....
And some medicine is wasted on the way...
And even after it is developed , all the marketing , keep the business going , and of course ,
no one do this hard work for many , many years for free , or even shareholders who investing in to a company for many years, they expecting appreciation ...
Righfuly those things are very important...
So it is a difficult judgment here ...
IMO..